N.M. Admin. Code § 16.19.20.68

Current through Register Vol. 35, No. 19, October 8, 2024

Section 16.19.20.68 - SCHEDULE IV

Shall consist of the drugs and other substances, by whatever official name, common or usual name, chemical name, or brand name designated, listed in this section.

A.DEPRESSANTS: Unless specifically exempt or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Alfaxalone;

(2) Alprazolam;

(3) Barbital;

(4) Chloral Betaine;

(5) Chloral Hydrate;

(6) Chlordiazepoxide;

(7) Clobazam;

(8) Clonazepam;

(9) Clorazepate;

(10) Clotiazepam

(11) Diazepam;

(12) Estazolam;

(13) Ethchlorvynol;

(14) Ethinamate;

(15) Flurazepam;

(16) Fospropofol;

(17) Halazepam;

(18) Lorazepam;

(19) Mebutamate;

(20) Meprobamate;

(21) Methohexital;

(22) Methylphenobarbital;

(23) Midazolam;

(24) Oxazepam;

(25) Paraldehyde;

(26) Petrichloral;

(27) Phenobarbital;

(28) Prazepam;

(29) Quazepam;

(30) Remimazolam;

(31) Suvorexant;

(32) Temazepam;

(33) Triazolam;

(34) Brexanolone.

B.LORCASERIN: Any material, compound, mixture or preparation which contains any quantity of the following substance, including its salts, isomers (whether optical, positional, or geometric) and its salts, or such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible: Lorcaserin.

C.STIMULANTS: Unless specifically exempt or unless listed in another schedule any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, positional, or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Diethylpropion;

(2) Phentermine;

(3) Pemoline (including organometallic complexes and chelates thereon);

(4) Pipradrol;

(5) SPA ((-)-1-dimethyl amino-1,2-diphenylmethane);

(6) Mazindol;

(7) Cathine;

(8) Fencamfamin;

(9) Fenproporex;

(10) Mefenorex;

(11) Modafinil;

(12) Sibutramine;

(13) Solriamfetol;

(14) Serdexmethylphenidate.

D.OTHER SUBSTANCES: Unless specifically exempt or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts:

(1) Dextropropoxyphene(Alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane);

(2) Pentazocine;

(3) Carisoprodol;

(4) Nalbuphine Hydrochloride;

(5) Butorphanol Tartrate;

(6) Dezocine;

(7) Dichloralphenazone;

(8) Zaleplon;

(9) Zolpidem;

(10) Eszopiclone;

(11) Tramadol;

(12) Eluxadoline (5--1-oxopropyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers

(13) Lemborexant;

(14) Daridorexant

E.NARCOTIC DRUG: Unless specifically exempt or unless listed in another schedule, any material, compound, mixture or preparation containing limited quantities of any of the following narcotic drugs or any salts thereof: Not more than one milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

F.EXEMPTION OF CHLORAL: When packaged in a sealed, oxygen-free environment, under nitrogen pressure, safeguarded against exposure to the air. Chloral when existing under the above conditions is a substance which is not intended for general administration to a human being or another animal, and contains no narcotic controlled substances and is packaged in such a form that the package quantity does not present any significant potential for abuse. All persons who engage in industrial activities with respect to such chloral are subject to registration; but shall be exempt from Section 30-31-16 through 19 of the New Mexico Controlled Substances Act and 16.19.20.19 NMAC through 16.19.20.52 NMAC of the board of pharmacy regulations.

G.EXEMPT COMPOUNDS: Librax and Menrium are preparations which contain chlordiazepoxide, a depressant listed in schedule IV, Paragraph (6) of Subsection A of 16.19.20.68 NMAC and other ingredients in such combinations, quantity, preparation or concentration as to vitiate the potential for abuse of chlordiazepoxide, and are hereby exempt preparations.

(1) Librax;

(2) Menrium, 5-2;

(3) Menrium, 4-5;

(4) Menrium, 10-4.

N.M. Admin. Code § 16.19.20.68

16.19.20.68 NMAC - Rp 16 NMAC 19.20.28(3), 07-15-02; A, 06-30-05; A, 05-14-10; A, 03-07-11; A, 08-31-12, Amended, New Mexico Register, Volume XXV, Issue 16, August 29, 2014, eff. 9/7/2014, Amended by New Mexico Register, Volume XXVI, Issue 22, November 30, 2015, eff. 12/13/2015, Amended by New Mexico Register, Volume XXVIII, Issue 05, March 14, 2017, eff. 3/29/2017, Adopted by New Mexico Register, Volume XXIX, Issue 12, June 26, 2018, eff. 6/26/2018, Amended by New Mexico Register, Volume XXXII, Issue 17, September 14, 2021, eff. 9/14/2021, Amended by New Mexico Register, Volume XXXIV, Issue 11, June 13, 2023, eff. 6/13/2023